Russian human cohort protocols
- Reported quantity
- Commonly 5–10 mg per administration
- Frequency
- Once daily
- Study duration
- 10-day courses, repeated periodically
The 10-day course is the structural signature of this entire peptide family.

Protocols · Cognitive
Pinealon belongs to the Khavinson short-peptide bioregulator family, alongside Epithalon and Cartalax. As with the rest of that family, the literature is regionally concentrated, small, and lightly replicated outside its originating institutes.
Read this first
Every figure on this page is a range reported in published literature or in a publicly documented study protocol. It is a record of what researchers used, not a recommendation, a therapeutic protocol, or advice. Peptide Intel Hub is an independent publication, sells nothing, and describes these compounds as in-vitro research reagents only.
Each row below describes one body of work. The model and population are part of the figure — a rodent per-kilogram quantity and a human trial quantity are not comparable.
The 10-day course is the structural signature of this entire peptide family.
Proposed mechanisms centre on direct peptide–DNA interaction, which remains contested.
These figures match the published chart for this compound on peptidedosages.com, including the reconstitution volume, resulting concentration, insulin-syringe units and the staged schedule. Educational reference only — not instructions, and not medical advice.
Pinealon · 20 mg Vial
Pinealon is dosed at 1 mg–2 mg daily via subcutaneous injection in educational protocols. A 20 mg vial reconstituted with bacteriostatic water yields about 6.67 mg/mL. This information is for research and educational use only.
| Days | Daily Dose | Units (per injection) (mL) |
|---|---|---|
| Days 1–5 | 1.0 mg (1,000 mcg) | 15 units (0.15 mL) |
| Days 6–14 | 1.5 mg (1,500 mcg) | 22.5 units (0.225 mL) |
| Days 15–20 | 2.0 mg (2,000 mcg) | 30 units (0.30 mL) |
A 10 mg vial in 2 mL of bacteriostatic water gives 5 mg/mL.
Open the reconstitution calculatorNo peer-reviewed primary literature reporting administered quantities exists for this item. Anything circulating online about quantities is anecdote rather than evidence, and this page will not reproduce it. The database links below are kept so you can check for yourself as new work is published.
Peptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.
Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Regena Peptides and Regena.app (regena-peptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Regena Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.